Form 4: LMFA Director Granted 104,760 Stock Options

Sentiment:

Insider Transaction Report


LM Funding America Director Frank Charles Silcox was granted 104,760 stock options with an exercise price of $1.26, vesting over one year.

Summary

  • Director Frank Charles Silcox of LM Funding America, Inc. (LMFA) was granted 104,760 stock options.
  • The options have an exercise price of $1.26 per share.
  • The grant date for these options was August 27, 2025.
  • The options expire on August 27, 2035.
  • The options were granted under the Non-Employee Director Compensation Plan, as amended on November 18, 2022.
  • Vesting occurs in two tranches: half on the 180th day after the grant date and the remaining half on the first anniversary of the grant date.

Sentiment

Score: 7

Explanation: Neutral to slightly positive. The grant of options is a standard compensation practice, aligning director interests with shareholders, which is generally viewed positively. No negative operational news is present.

Positives

  • Granting of stock options aligns director incentives with shareholder value creation.
  • The options have a 10-year expiration, providing a long-term incentive for the director.

Negatives

  • No immediate cash benefit to the director; value is contingent on stock price appreciation above the exercise price.

Risks

  • The value of the options is subject to the future performance of LMFA's stock price. If the stock price does not exceed the $1.26 exercise price, the options may expire worthless.

Future Outlook

The options granted will vest in two equal tranches: one-half on the 180th day after the grant date (August 27, 2025) and the remaining one-half on the first anniversary of the grant date (August 27, 2026).

Industry Context

Granting stock options to non-employee directors is a common practice in corporate governance across various industries, including financial services, to align their long-term interests with those of shareholders.

Comparison to Industry Standards

  • Granting stock options to non-employee directors is a common compensation practice across various industries.
  • Without specific peer company data or compensation benchmarks within the filing, a detailed comparison to industry standards for the specific number of options or exercise price is not feasible based solely on this document.

Related Party Transactions

  • The grant of stock options to Frank Charles Silcox, a director of LM Funding America, Inc., constitutes a related party transaction as he is an insider.

Stakeholder Impact

  • Shareholders: Potential for future dilution if options are exercised, but also enhanced alignment of director incentives with long-term shareholder value creation.
  • Director (Frank Charles Silcox): Receives a significant long-term equity incentive, contingent on the company's stock performance above the exercise price.

Next Steps

  • The options will vest in two tranches: half on the 180th day after the grant date (February 23, 2026) and half on the first anniversary of the grant date (August 27, 2026).
  • The director may choose to exercise the vested options at any time before the expiration date of August 27, 2035, assuming the stock price is above the exercise price.

Key Dates

DateDescription
11/18/2022Date the Non-Employee Director Compensation Plan was amended, under which the options were granted.
08/27/2025Grant date of 104,760 stock options to Director Frank Charles Silcox.
08/28/2025Signature date of the reporting person on the Form 4 filing.
02/23/2026Estimated vesting date for one-half (52,380) of the granted options (180 days after grant date).
08/27/2026Vesting date for the remaining one-half (52,380) of the granted options (first anniversary of grant date).
08/27/2035Expiration date of the stock options.

Recommendation

hold

This Form 4 filing reports a routine grant of stock options to a director as part of their compensation. It does not contain any new operational, financial, or strategic information that would warrant a change in investment thesis. The grant aligns director incentives with shareholder value but does not provide a basis for a 'buy' or 'sell' recommendation on its own.

Keywords

LMFA, LM Funding America, Stock Options, Director Compensation, Insider Transaction, SEC Form 4, Equity Grant, Executive Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.